ImmuPharma (AIM:IMM, FRA:25I) says it's on track to deliver a licensing deal for its lead asset P140 this year. The company has also fast-tracked Kapiglucagon, a next-gen diabetes treatment, backed by funding from Lanstead Capital.
Ilika (AIM:IKA, OTCQX:ILIKF, FRA:I8A) has had its Goliath solid-state batteries tested under battlefield conditions — including live-fire testing. The results demonstrated the inherent safety advantages of Ilika's solid-state battery technology compared to traditional lithium-ion alternatives
Coinsilium (AQSE:COIN, OTCQB:CINGF, FRA:5CT) is betting on prediction markets as its big focus for 2026. The sector is already worth over $65 billion, and the company is investing in Prediction Labs, which sits in the data infrastructure layer of the market.
IP Group (LSE:IPO) posted 13% growth in NAV per share for 2025. Highlights include a near 50x return from the Hinge Health IPO and a £130 million valuation tied to Pfizer's obesity drug pipeline.
Team Internet Group (AIM:TIG, OTCQX:TIGXF, FRA:4CN) says its transition year is done, with 80% of EBITDA now coming from its more stable domains and comparison platforms. The company is also reviewing a potential sale of the DIS division, with any proceeds targeted at repaying debt and rewarding shareholders.
Follow us and subscribe on YouTune, our social channels, and on proactiveinvestors.co.uk.
